760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
ID: 36C77025Q0079Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/1dcd63267b5641e99c0c9388ce147548/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_JnA_Q0079_allsigned.pdf
    The Department of Veterans Affairs is seeking to procure five specific brand name pharmaceuticals for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under the Simplified Acquisition Procedures outlined in FAR 13.5. The justification for sole-source procurement highlights that only the unique products can fulfill the requirements established by physician prescriptions, with no substitutions permitted due to clinical evaluations by Pharmacy Benefits Management (PBM). The procurement will be a firm-fixed-price contract, with delivery expected within ten days after receipt of order. Market research, conducted to assess available sources, confirmed that Abbvie, the original equipment manufacturer (OEM) of the specified products, does not have registered small business distributors that meet the necessary criteria under the Non-Manufacturer Rule. Consequently, competition is restricted as no other suppliers can provide the required pharmaceuticals, aligning with regulatory provisions. Although previous contracts involved both large and small businesses, only qualified vendors complying with Drug Supply Chain Security Act requirements will be solicited. The anticipated cost is expected to be fair based on historical data and market evaluations, ensuring compliance with procurement guidelines. Overall, this acquisition underlines the VA's commitment to providing specific medications to veterans while adhering to regulatory and market procedures.
    S02_Pre_Sol_36C77025Q0079_final_.pdf
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Armour Thyroid tablets for the Leavenworth CMOP facility, located at 5000 S. 13th Street, Leavenworth, Kansas. The solicitation number for this request is 36C77025Q0079, with bids due by December 27, 2024, at 4 PM Central Time. This contract is classified under the product service code 6505 (Drug and Biologicals) and the NAICS code 325412 (Pharmaceutical Preparation Manufacturing). A total of five different Armour Thyroid tablet variants, ranging from 30-180mg, are required in specific quantities and packaging configurations. Vendors must be registered in SAM.gov and submit their proposals via email, including essential documentation such as the signed SF1449 solicitation cover page, pricing schedule, applicable licenses, and a Buy American Act Certificate if necessary. Timely and compliant submissions are critical, as incomplete packages will be rejected. This effort underscores the VA’s commitment to ensuring a stable supply of essential medications for veterans' care while promoting compliance with federal regulations.
    S02_Pricing Schedule_Q0079.xlsx
    The document pertains to a Request for Quotation (RFQ) for pharmaceutical supplies from the Leavenworth CMOP, with a specific focus on the procurement of various dosages of Armour Thyroid tablets. The RFQ identifies necessary documentation, including a signed solicitation cover page (SF1449), a quote spreadsheet, and compliance with the Buy American Act (BAA). Vendors must submit their quotes by December 27, 2024, by 4:00 PM CST, with a requirement for only one submission per vendor. Key products listed include multiple strengths of Armour Thyroid tablets, with specific quantities requested. Each submission must detail unit pricing, total pricing, and product expiration dates, ensuring a minimum shelf life of one year from delivery. Additional requirements include a state wholesale distributor license, and if applicable, a subcontracting plan. This RFQ reflects government efforts to secure essential pharmaceuticals, ensuring compliance with federal regulations and prioritizing quality supply chains for healthcare provisions. Overall, it serves the objective of facilitating a streamlined procurement process while adhering to regulatory stipulations.
    S02_RFQ_36C77025Q0079_.pdf
    The document outlines a federal Request for Proposal (RFP) from the Department of Veterans Affairs (VA), specifically for the acquisition of pharmaceutical products for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP). It specifies that the solicitation (number 36C77025Q0079) is open to all businesses, but emphasizes a goal for small business participation. The RFP includes instructions for submissions, including the requirement for a signed Standard Form 1449 and an Excel pricing schedule. Key components of the RFP involve detailing the specific pharmaceutical items requested, delivery schedules, and adherence to labeling standards such as bar coding requirements compliant with industry regulations. Additionally, it establishes conditions regarding recalls, product quality, and compliance with the Drug Supply Chain Security Act. The RFP is meticulously structured, including sections on general terms and conditions, price/cost schedules, and delivery expectations. The document stresses the importance of compliance with various federal regulations, including FAR and VAAR clauses. This procurement process exemplifies the government's commitment to sourcing pharmaceutical supplies while promoting transparency, process adherence, and support for small businesses within the federal contracting framework.
    Similar Opportunities
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0059 762-25-1-040-0124 -Tucson CMOP ATORVASTATIN CALCIUM -(VA-25-00015524)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Atorvastatin Calcium 80mg tablets to be delivered to its Tucson CMOP facility. This contract is specifically set aside for small businesses and requires compliance with the Buy American statute, necessitating separate quotes for foreign and domestic products. The pharmaceuticals are critical for the healthcare of veterans, emphasizing the importance of responsible sourcing and regulatory compliance in the pharmaceutical supply chain. Interested vendors must submit their proposals via email to Jeffrey Blackard by December 26, 2024, at 09:00 AM Central Time, with the anticipated award date set for December 30, 2024.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.